<font color="blue">Effects_1</font> <font color="blue">of_1</font> <font color="blue">low_1</font> <font color="blue">-_1</font> <font color="blue">dose_1</font> <font color="blue">aspirin_1</font> on <font color="blue">clinic_3</font> <font color="blue">and_3</font> <font color="blue">ambulatory_4</font> <font color="blue">blood_5</font> <font color="blue">pressure_5</font> in treated hypertensive patients . Collaborative Group of the Primary Prevention Project ( PPP)--Hypertension study . 
<br>
<br> Nonsteroidal antiinflammatory drugs may affect <font color="blue">blood_3</font> <font color="blue">pressure_3</font> <font color="blue">(_3</font> <font color="blue">BP_3</font> <font color="blue">)_3</font> <font color="blue">control_3</font> in hypertensive patients receiving drug treatment , but data on the <font color="blue">effects_1</font> <font color="blue">of_1</font> <font color="blue">low_1</font> <font color="blue">-_1</font> <font color="blue">dose_1</font> <font color="blue">aspirin_1</font> are scanty . This study assessed the <font color="blue">effects_2</font> <font color="blue">of_2</font> <font color="blue">chronic_2</font> <font color="blue">treatment_2</font> <font color="blue">with_1</font> <font color="blue">low_1</font> <font color="blue">doses_1</font> <font color="blue">of_1</font> <font color="blue">aspirin_1</font> ( 100 mg / day ) on <font color="blue">clinic_3</font> <font color="blue">and_3</font> <font color="blue">ambulatory_3</font> <font color="blue">systolic_4</font> <font color="blue">(_4</font> <font color="blue">SBP_4</font> <font color="blue">)_4</font> <font color="blue">and_4</font> <font color="blue">diastolic_4</font> <font color="blue">(_4</font> <font color="blue">DBP_4</font> <font color="blue">)_4</font> <font color="blue">BP_4</font> <font color="blue">in_1</font> <font color="blue">hypertensives_1</font> on chronic , stable antihypertensive therapy . The study was conducted in the framework of the Primary Prevention Project ( PPP ) , a randomized , controlled factorial trial on the <font color="blue">preventive_2</font> <font color="blue">effect_2</font> <font color="blue">of_2</font> <font color="blue">aspirin_2</font> <font color="blue">or_2</font> <font color="blue">vitamin_2</font> <font color="blue">E_2</font> in people with one or more cardiovascular risk factors . Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 + /- 5.9 years ) treated with different antihypertensive drugs : 71 patients were randomized to aspirin and 71 served as controls . All patients underwent a <font color="blue">clinic_2</font> <font color="blue">BP_3</font> <font color="blue">evaluation_1</font> <font color="blue">with_1</font> <font color="blue">an_1</font> <font color="blue">automatic_1</font> <font color="blue">sphygmomanometer_1</font> <font color="blue">and_1</font> <font color="blue">a_1</font> <font color="blue">24-h_2</font> <font color="blue">ambulatory_3</font> <font color="blue">BP_3</font> <font color="blue">monitoring_2</font> <font color="blue">,_2</font> at baseline and after 3 months of aspirin treatment . At the end of the study the changes in <font color="blue">clinic_4</font> <font color="blue">SBP_5</font> <font color="blue">and_4</font> <font color="blue">DBP_5</font> were not statistically different in treated and untreated subjects . <font color="blue">Ambulatory_4</font> <font color="blue">SBP_5</font> <font color="blue">and_5</font> <font color="blue">DBP_5</font> after 3 months of aspirin treatment were similar to baseline : <font color="blue">deltaSBP_1</font> -0.5 mmHg ( 95% confidence intervals [ CI ] from -1.9 to + 2.9 mm Hg ) and <font color="blue">deltaDBP_1</font> -1.1 mm Hg ( 95% CI from -2.5 to + 0.3 mm Hg ) . The pattern was similar in the control group . No <font color="blue">interaction_1</font> was found between aspirin and the most used antihypertensive drug classes ( angiotensin converting enzyme inhibitors and calcium antagonists ) . Despite the relatively small sample size our results seem to exclude any significant <font color="blue">influence_1</font> <font color="blue">of_1</font> <font color="blue">low_1</font> <font color="blue">-_1</font> <font color="blue">dose_1</font> <font color="blue">aspirin_1</font> <font color="blue">on_1</font> <font color="blue">BP_3</font> <font color="blue">control_3</font> in hypertensives under treatment .